Spruce Biosciences Sets New Director Compensation Terms with Stock Options and Retainers
I'm PortAI, I can summarize articles.
Spruce Biosciences Inc. has appointed Keli Walbert to its board of directors. Walbert will receive a stock option to purchase 3,400 shares, vesting over three years, and an annual cash retainer of $40,000, plus $5,000 for serving on the Compensation Committee, pro-rated for 2025. From 2026, the retainer increases to $5,500, and she will be eligible for an annual stock option to purchase 1,700 shares.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments